Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Dysfunction of the Methyl-CpG-binding protein 2 (MeCP2) is linked to neurological disorders like Rett syndrome and Autism.
• Contradictory data exist regarding MeCP2 protein's molecular weight, with western blots typically showing a single band around 75 kDa, yet other reports indicate multiple immunoreactive bands.
• These multiple bands are debated, with some suggesting cross-reactivity or degradation, while others propose post-transcriptional modifications generating diverse MeCP2 forms.

Purpose of the Study:

• To investigate the existence and nature of multiple MeCP2 immunoreactive bands in neural cells.
• To analyze these bands in both control cells and cells expressing a specific p.T158M MeCP2e1 mutant.

Main Methods:

• Generation of stable cell lines expressing wild-type and p.T158M MeCP2e1-RFP constructs.
• Western blot analysis using N-terminal, C-terminal MeCP2 antibodies, and an RFP antibody to ensure specificity.
• Comparison of MeCP2 band patterns between wild-type and mutant cell lines.

Main Results:

• Multiple MeCP2 immunoreactive bands were confirmed in control, wild-type, and p.T158M MeCP2e1-RFP mutant cells.
• Distinct differences in MeCP2 band patterns were observed between wild-type and mutant cells.
• A slower migrating phosphorylated band (around 70 kDa) was absent in the p.T158M MeCP2e1-RFP mutant cells, suggesting threonine 158 is a key phosphorylation site.

Conclusions:

• MeCP2 antibodies exhibit no significant cross-reactivity, supporting the existence of multiple MeCP2 molecular forms.
• Variations in the molecular pattern of MeCP2, potentially due to altered post-transcriptional processing, may contribute to Rett syndrome pathophysiology.
• Threonine 158 is indicated as an important phosphorylation site potentially involved in MeCP2 protein function.